Skip to main content

Blood Test Identifies Gene Deformity Known As Lynch Syndrome

MANSFIELD, OH -  A network of 50 hospitals, including OhioHealth MedCentral Mansfield, are joining forces across the Buckeye State, using a blood test to identify those most at risk for a gene deformity known as Lynch Syndrome and to help them avoid a diagnosis of cancer.
Lynch Syndrome is a condition that prevents your body from properly repairing damaged D-N-A.
When that happens, your risk of getting cancer at some point in your life is very high.
The good news is, a simple blood test can tell you if you have Lynch Syndrome.
And 50 hospitals across Ohio have joined forces to test for it.
In many cases, the tests are free of charge.
Experts at The Ohio State University Comprehensive Cancer Center say if you or a close relative has been diagnosed with colorectal cancer since 2013, you should consider a test for Lynch Syndrome.

Read More:  http://www.wmfd.com/news/single.asp?story=70230

Comments

Post a Comment

Popular posts from this blog

Get the Facts About Genetic Colon Cancer

Get the Facts: http://genefacts.org Lynch syndrome is a cancer predisposition syndrome caused by inherited mutations in genes responsible for correcting DNA replication errors. Individuals with Lynch syndrome have a greatly increased risk for colorectal, endometrial, and stomach cancers, and a moderately increased risk for other cancers. Key Points 1-3% of colon cancers attributable to Lynch syndrome Dominant inheritance with reduced penetrance (not all patients with mutations will manifest disease) Diagnosis based on clinical and family history, tumor pathology and/or genetic testing Screening and prophylactic surgeries effective in reducing some, but not all cancer risks Mutations in any of several genes can cause the syndrome
Post a Comment
Read more

Cancer Survivors

Just read a story about one woman's cancer experience. I bet everyone has a story about what goes through your mind when you are told you have cancer. Her thought were about her stunned family members, one crying and the other in shock. I bet there are quite a few stories that could be qualitatively studied. Those experiences could help nurses better help patients during this time.
1 comment
Read more

My Publication, "Hereditary non-polyposis colon cancer: change the name to protect the innocent." Cited in World Journal of Gastroenterology

Estradiol agonists inhibit human LoVo colorectal-cancer cell proliferation and migration t... Hsi-Hsien Hsu, Wei-Wen Kuo, Da-Tong Ju... World journal of gastroenterology : WJG 11/2014 20(44):16665-73. World Journal of Gastroenterology : WJG 11/2014; 20(44):16665-73. DOI: 10.3748/wjg.v20.i44.16665 Source: PubMed ABSTRACT To investigate the effects of 17β-estradiol via estrogen receptors (ER) or direct administration of ER agonists on human colorectal cancer. LoVo cells were established from the Bioresource Collection and Research Center and cultured in phenol red-free DMEM (Sigma, United States). To investigate the effects of E2 and/or ER selective agonists on cellular proliferation, LoVo colorectal cells were treated with E2 or ER-selective agonists for 24 h and 48 h and subjected to the MTT (Sigma) assay to find the concentration. And investigate the effects of E2 and/or ER selective agonists on cell used western immunoblotting to find out the diver...
Post a Comment
Read more